SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
-2.88%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$242M
AUM Growth
+$242M
(+3.8%)
Cap. Flow
+$16.7M
Cap. Flow
% of AUM
6.9%
Top 10 Holdings %
Top 10 Hldgs %
34.33%
Holding
60
New
15
Increased
15
Reduced
14
Closed
11
Top Buys
| 1 |
Centene
CNC
|
$5.89M |
| 2 |
Novo Nordisk
NVO
|
$5M |
| 3 |
Cigna
CI
|
$4.79M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
$4.49M |
| 5 |
Medtronic
MDT
|
$3.88M |
Top Sells
| 1 |
Pfizer
PFE
|
$5.91M |
| 2 |
Eli Lilly
LLY
|
$5.01M |
| 3 |
Becton Dickinson
BDX
|
$4.4M |
| 4 |
Bristol-Myers Squibb
BMY
|
$4.37M |
| 5 |
Molina Healthcare
MOH
|
$3.98M |
Sector Composition
| 1 | Healthcare | 93.04% |
| 2 | Energy | 1.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Becton Dickinson
BDX
$55.3B
| – | – |
-17,500
| Closed | -$4.4M |
|
|
52
Bristol-Myers Squibb
BMY
$96B
| – | – |
-70,000
| Closed | -$4.37M |
|
|
BPMC
53
DELISTED
Blueprint Medicines
BPMC
| – | – |
-10,000
| Closed | -$1.07M |
|
54
CRISPR Therapeutics
CRSP
$4.71B
| – | – |
-25,000
| Closed | -$1.9M |
|
55
Edwards Lifesciences
EW
$47.8B
| – | – |
-15,068
| Closed | -$1.95M |
|
|
56
Molina Healthcare
MOH
$9.8B
| – | – |
-12,500
| Closed | -$3.98M |
|
|
57
Pfizer
PFE
$141B
| – | – |
-100,000
| Closed | -$5.91M |
|
58
Sarepta Therapeutics
SRPT
$1.78B
| – | – |
-25,000
| Closed | -$2.25M |
|
59
West Pharmaceutical
WST
$17.8B
| – | – |
-7,500
| Closed | -$3.52M |
|
|
MRTX
60
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| – | – |
-9,918
| Closed | -$1.46M |
|